Indications for: AKINETON

Adjunct in the therapy of all forms of parkinsonism (eg, idiopathic, postencephalitic, arteriosclerotic). To control extrapyramidal disorders secondary to neuroleptic drug therapy (eg, phenothiazines).

Adult Dosage:

Parkinson's disease: 2mg three or four times daily. Individualize and titrate upward to max 16mg/24 hours. Extrapyramidal disorders: 2mg one to three times daily.

Children Dosage:

Not recommended.

AKINETON Contraindications:

Narrow angle glaucoma. Bowel obstruction. Megacolon.

AKINETON Warnings/Precautions:

Glaucoma. Prostatism. Epilepsy. Arrhythmia. Pregnancy (Cat.C). Nursing mothers.

AKINETON Classification:


AKINETON Interactions:

Avoid concomitant alcohol. Potentiated anticholinergic effects with drugs that have secondary anticholinergic actions (eg, narcotics analgesics, phenothiazines, tricyclic antidepressants, antiarrhythmics, antihistamines).

Adverse Reactions:

Anticholinergic effects (eg, dry mouth, blurred vision, drowsiness, euphoria, disorientation, urinary retention, postural hypotension, constipation, agitation, disturbed behavior); rare: generalized choreic movements, reduction in REM sleep.

How Supplied: